Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How important is optimal blood pressure control?

Gordon T McInnes1

  • 1Division of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, Glasgow, United Kingdom. gordon.t.mcinnes@clinmed.gla.ac.uk

Clinical Therapeutics
|August 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.

The lancet. Diabetes & endocrinology·2018
Same author

Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.

European heart journal·2015
Same author

Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.

Hypertension (Dallas, Tex. : 1979)·2015
Same author

Response to Effect of serum chloride on mortality in hypertensive patients.

Hypertension (Dallas, Tex. : 1979)·2014
Same author

Serum chloride is an independent predictor of mortality in hypertensive patients.

Hypertension (Dallas, Tex. : 1979)·2013
Same author

Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension.

Hypertension (Dallas, Tex. : 1979)·2013
Same journal

Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

Clinical therapeutics·2026
Same journal

Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

Clinical therapeutics·2026
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
See all related articles

Achieving optimal blood pressure control significantly reduces cardiovascular risk, especially in high-risk patients. Angiotensin II receptor antagonists (sartans) offer an effective and well-tolerated option for improved hypertension management.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Antihypertensive treatment offers robust cardiovascular benefits, with even minor blood pressure reductions improving outcomes.
  • Optimal blood pressure control is crucial, particularly for high-risk individuals like those with type 2 diabetes mellitus.

Purpose of the Study:

  • To discuss optimal blood pressure targets and review antihypertensive treatment effects in high-risk patients.
  • To present current hypertension guidelines and address global challenges in achieving blood pressure control.
  • To suggest strategies for enhancing hypertension treatment efficacy.

Main Methods:

  • Review of randomized, prospective studies on antihypertensive treatment.
  • Analysis of national and international hypertension management guidelines.
  • Evaluation of treatment adherence and drug tolerability, including angiotensin II receptor antagonists (sartans).

Related Experiment Videos

Main Results:

  • Small improvements in blood pressure control yield substantial reductions in cardiovascular risk for high-risk patients.
  • Despite strong evidence, hypertension remains underdiagnosed and undertreated globally.
  • Rigorous blood pressure targets are recommended by guidelines but rarely achieved.

Conclusions:

  • Optimal blood pressure control is essential for reducing cardiovascular risk.
  • Combination therapy, particularly with well-tolerated agents like sartans, can improve treatment success.
  • Early use of sartans and recognition of benefits from small blood pressure reductions can facilitate better control.